This website used cookies to give you the best experience. By continuing to use this website you are consenting to cookies being used. You can delete and block cookies from within your browsers settings. For more information please refer to our privacy policy page.
Vokanamet is the combination of 2 drugs: canagliflozin and metformin. Canagaliflozin is mainly used for treatment of type 2 diabetes. Metformin is also used to treat high blood sugar levels caused by Type 1 or Type 2 diabetes. The two active drugs in Vokanamet work in combination to restore your body into a basal metabolic state. Canagaliflozin acts on the kidneys and assists in the riddance of sugar from your bloodstream via urine. Whereas metformin improves insulin sensitivity by increasing sugar uptake, lowering liver glucose production, and decreasing intestinal glucose absorption. Common side effects associated with taking Vokanamet include: headache, weakness, nausea, vomiting, and frequent urination.
Vokanamet® is a registered trademark of Janssen Pharmaceuticals, Inc.
Note:
Success: Your login details have been sent and should arrive shortly.